Osteonecrosis of the External Auditory Canal Associated With Oral Sorafenib Therapy: Sorafenib and Temporal Bone Osteonecrosis
Conclusion:
Medication-related osteonecrosis of the temporal bone is not a well-known entity among otolaryngologists and could therefore be misclassified as another diagnosis. In patients with othorrea and earache following sorafenib treatment, temporal bone osteonecrosis should be suspected.
Source: Otology and Neurotology - Category: ENT & OMF Tags: MIDDLE EAR AND MASTOID DISEASE Source Type: research
More News: Brain | Cancer | Cancer & Oncology | CT Scan | ENT & OMF | Kidney Cancer | Neurology | Oral Cancer | Otitis | Otitis Externa (Swimmer's Ear) | Otoscopy | Renal Cell Carcinoma | Skin | Temporomandibular Disorders